Paper Details

  1. Home
  2. Paper Details

Intravenous sulbactam/ampicillin in the treatment of pediatric infections.

Author: ChenC M, ChuM L, HsuC Y, HuangL M, LeeC Y, LeeM J, LinT Y

Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Sulbactam/ampicillin was effective in treating common pediatric infections, with a 96.4% cure rate and a low incidence of side effects.
Paper Details　
Original Abstract of the Article :
A total of 82 patients involving 83 episodes of proven or presumed bacterial infection were treated with sulbactam/ampicillin. These included 36 cases of soft tissue infection or abscess, four cases of joint or bone infection, 20 cases of respiratory tract infection (17 cases of pneumonia, two of ot...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/0732-8893(89)90133-8

データ提供：米国国立医学図書館（NLM）

Intravenous sulbactam/ampicillin in the treatment of pediatric infections

This study ventures into the fascinating world of pediatric infections, like exploring a hidden oasis in the desert. The researchers sought to determine the efficacy of intravenous sulbactam/ampicillin in treating a range of bacterial infections in children. They used their research as a compass, guiding them through a diverse group of 82 patients, encompassing 83 separate infection episodes.

How effective is sulbactam/ampicillin in treating pediatric infections?

The researchers found that sulbactam/ampicillin was highly effective in treating a variety of pediatric infections, like a sturdy camel navigating through the challenges of the desert. In 80 out of 83 episodes, the patients either recovered fully or showed significant improvement. The drug also proved effective in eliminating bacteria in 46 out of 49 infections. The researchers, like skilled navigators, also observed few side effects, demonstrating the safety and efficacy of this powerful drug.

The importance of effective antibiotics for children and their health

This study highlights the importance of having effective antibiotics available to treat children with infections. It's like having a reliable source of water in the desert, providing a vital resource to overcome the challenges of illness. The research serves as a beacon of hope for parents and caregivers dealing with pediatric infections, offering a safe and effective treatment option for their little ones.

Dr.Camel's Conclusion

This study is a testament to the power of research in finding safe and effective treatments for children suffering from infections. The researchers have demonstrated that sulbactam/ampicillin is a valuable tool for treating a variety of pediatric infections.
Date :
  1. Date Completed 1990-01-17
  2. Date Revised 2019-09-03
Further Info :

Pubmed ID

2686918

DOI: Digital Object Identifier

10.1016/0732-8893(89)90133-8

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.